[{"uuid": "4a3757a7-02cf-3353-a187-6bcaaeaa0a19", "title": "Enveric Biosciences Announces Closing of $5 Million Public Offering", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/enveric-biosciences-announces-closing-5-220000824.html", "providerPublishTime": 1738620000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/XOfUzb.dz_ykdoKZh2XDIg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/a50313073ce03c9993faf534772bc3b6", "width": 1024, "height": 512, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/vsVtE1N4e15fIwCI9e9vPw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/a50313073ce03c9993faf534772bc3b6", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ENVB"]}, {"uuid": "ab369c35-40b4-361f-8303-21a1eab76834", "title": "Weekly Roundup on the Cannabis Sector & Psychedelic Sector", "publisher": "Market Exclusive", "link": "https://finance.yahoo.com/news/weekly-roundup-cannabis-sector-psychedelic-132434859.html", "providerPublishTime": 1738589074, "type": "STORY", "relatedTickers": ["SMG", "OPTHF", "AWKNF", "ATAI", "HITI"]}, {"uuid": "57ac2321-89a3-3473-b4af-f9f4349c1738", "title": "Enveric Biosciences Prices $5 Million Public Offering; Shares Drop 40% in Premarket Trading", "publisher": "GuruFocus.com", "link": "https://finance.yahoo.com/news/enveric-biosciences-prices-5-million-141737847.html", "providerPublishTime": 1738333057, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/P3USSRknj54CkoonZHgmKA--~B/aD05ODU7dz0yMTI3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/8b34282df3e337e017d4d48d8d2bb143", "width": 2127, "height": 985, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/6pnKxd16bn7btnJm6ez2Tw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/8b34282df3e337e017d4d48d8d2bb143", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ENVB"]}, {"uuid": "04ef0070-18fe-3e44-be51-51df4d34fe7e", "title": "Enveric Biosciences Announces Pricing of $5 Million Public Offering", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/enveric-biosciences-announces-pricing-5-011400749.html", "providerPublishTime": 1738286040, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/fpTmGLhXoSWwI7uoALEYRg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f021e78605d507f901d927c8f7265c88", "width": 1024, "height": 512, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/hsIMAgzzSZlHf23WfRVbRQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f021e78605d507f901d927c8f7265c88", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ENVB"]}, {"uuid": "38977a71-7406-3524-ba2b-b3e97518be49", "title": "Enveric Biosciences Receives Notice of Allowance for Lead Drug Candidate EB-003 from United States Patent and Trademark Office", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/enveric-biosciences-receives-notice-allowance-210100668.html", "providerPublishTime": 1738270860, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/WTqwUKcxkoNUy8_lowV7fg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/34484979e7d5994bfb8d6f1183948c90", "width": 1024, "height": 512, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/I.6SpXk3WuKdl9gKsxEJaA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/34484979e7d5994bfb8d6f1183948c90", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ENVB"]}, {"uuid": "e67686f5-9b44-3865-8866-44fbabb60cbc", "title": "Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During \"J.P. Morgan Week 2025\"", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/enveric-biosciences-present-participate-panel-133000413.html", "providerPublishTime": 1736172600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/mjaYQuLhX3UNtsxxJfYKZg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/40e2824db6a500d690f8814ed71a752d", "width": 1024, "height": 512, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/v_CEaepwiCZ72zeeWvNxNw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/40e2824db6a500d690f8814ed71a752d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ENVB"]}, {"uuid": "c3ee1025-c9f8-3cc3-beec-290b83834900", "title": "Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/enveric-biosciences-announces-u-patents-130000109.html", "providerPublishTime": 1733144400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/hbboVI_mA8gAyavGWlrKfg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/943344feb3e07dc0fb78f98e753450a4", "width": 1024, "height": 512, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/wwzomkj0YZHOYr4ajGl1vw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/943344feb3e07dc0fb78f98e753450a4", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ENVB"]}, {"uuid": "75a890a7-5140-3f80-a97d-48631483027c", "title": "Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/enveric-biosciences-preclinical-pharmacokinetic-studies-140000385.html", "providerPublishTime": 1732543200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ix0S1GeKMDkIH7Dl8UY0Nw--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/663575da7294f843b11df744b7dd49d9", "width": 1024, "height": 512, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/yenGiPp4XLaEDdCtGdV9gQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/663575da7294f843b11df744b7dd49d9", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ENVB"]}, {"uuid": "45934d8b-3b78-3cc6-b87f-590826b2cbf9", "title": "Enveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/enveric-biosciences-signs-licensing-agreement-140000075.html", "providerPublishTime": 1731420000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Zy0k6fRklJPSnUKbTMvJqQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/21b14911079d8dd0f3c0b836aebb1254", "width": 1024, "height": 512, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/2Dgdb44jsWV9yyRkdqBRXA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/21b14911079d8dd0f3c0b836aebb1254", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ENVB"]}, {"uuid": "f335c8bc-ad02-3582-ae3f-dd1339645ca1", "title": "Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/enveric-biosciences-reports-third-quarter-210500814.html", "providerPublishTime": 1731618300, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qL.DXHBifUWLV72YOaWw2Q--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/db6c1436d30797554f9223a01ed0a784", "width": 1024, "height": 512, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/LZGt_fZJr7_6qkzpxvMEog--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/db6c1436d30797554f9223a01ed0a784", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ENVB"]}]